Stephen Kamin, MD, Chief of Service
The Stroke Center is New Jersey’s only academically based comprehensive stroke program and was established to provide early diagnosis and management of acute stroke and to reduce the disability and mortality from stroke. The Center, which operates 24/7, integrates multiple disciplines in the care of stroke patients, including interventional neuro-radiology, cardiology, neurosurgery, vascular surgery, nursing, nutrition, social work services and physical, speech and occupational therapies.
The Center provides specialized neuro-intensive care and a step-down Stroke Unit, with dedicated intensive care medical and nursing staff, physical rehabilitation services for stroke and cerbrovascular trauma and stroke prevention and early intervention services.
Advanced diagnostic capabilities at the Center include brain imaging tests, computed axial tomography (CAT or CT) scans, magnetic resonance imaging (MRI), blood flow tests, carotid ultrasound, cerebral angiography, computed tomographic angiography (CT angiography or CT-A), magnetic resonance angiography (MRA) and transcranial doppler (TCD)
The Center is staffed and equipped to evaluate, treat and prevent all forms of stroke and vascular conditions leading to stroke. Treatment modalities include surgical and drug treatments, as well as innovative endovascular (intra-arterial) procedures originally developed for use in the heart including mechanical clot-busting, angioplasty with stenting and, the Center has pioneered use of drug eluted stents and embolic protection in the removal of blockages in the brain.
The Center maintains active involvement in research supported by the National Institutes of Health (NIH), medical foundations and other sources.
Currently, the Center is a principal investigator for a nationwide, multi-center study comparing two drugs commonly used in stroke prevention: Warfarin vs. Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial. The study will determine which of two commonly used treatments is better for preventing death and stroke.
Another trial, the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) is looking at the use of these procedures in treating carotid artery stenosis to prevent strokes in patients who have had a TIA or mile ischemic stroke.
Stephen Kamin, MD